Malik E. Juweid
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
-
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 35
- Medical Imaging Techniques and Applications 24
- Monoclonal and Polyclonal Antibodies Research 13
- Radiomics and Machine Learning in Medical Imaging 12
-
- Lymphoma Diagnosis and Treatment 43
- Co-authors
- Bruce D. Cheson (8 shared papers)Sigrid Stroobants (4 shared papers)Julie M. Vose (7 shared papers)Ahmad Tamimi (8 shared papers)Randy D. Gascoyne (5 shared papers)Sandra J. Horning (4 shared papers)Beate Pfistner (3 shared papers)Volker Diehl (3 shared papers)
- Journals
- Blood (10 papers)Cancer (8 papers)Journal of Clinical Oncology (7 papers)Nuclear Medicine Communications (6 papers)Medicine (4 papers)
- Partner nations
- United StatesJordanGermany
In The Last Decade
Malik E. Juweid
124 papers receiving 8.7k citations
Malik E. Juweid's Hit Papers
Peers
Comparison fields: 5 of 149
- Pathology and Forensic Medicine 4.4k
- Radiology, Nuclear Medicine and Imaging 2.9k
- Neurology 1.3k
- Genetics 888
- Oncology 2.1k
Countries citing papers authored by Malik E. Juweid
This map shows the geographic impact of Malik E. Juweid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malik E. Juweid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malik E. Juweid more than expected).
Fields of papers citing papers by Malik E. Juweid
This network shows the impact of papers produced by Malik E. Juweid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malik E. Juweid. The network helps show where Malik E. Juweid may publish in the future.
Co-authors
The 25 scholars most cited alongside Malik E. Juweid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised Response Criteria for Malignant Lymphoma Hit paper breakdown → | 2007 | 3270 |
| 2 | Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma Hit paper breakdown → | 2007 | 1022 |
| 3 | Positron-Emission Tomography and Assessment of Cancer Therapy Hit paper breakdown → | 2006 | 593 |
| 4 | Epidemiology and Outcome of Glioblastoma Hit paper breakdown → | 2017 | 361 |
| 5 | Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. | 1992 | 360 |
| 6 | Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. | 1990 | 320 |
| 7 | 2005 | 288 | |
| 8 | 2007 | 226 | |
| 9 | 2006 | 141 | |
| 10 | Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. | 1995 | 141 |
| 11 | Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma. | 1999 | 109 |
| 12 | Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody. | 1995 | 103 |
| 13 | 2009 | 101 | |
| 14 | Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. | 1997 | 101 |
| 15 | Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. | 2002 | 90 |
| 16 | Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. | 1996 | 74 |
| 17 | 1997 | 73 | |
| 18 | 1999 | 72 | |
| 19 | 2006 | 71 | |
| 20 | 2010 | 71 |
About Malik E. Juweid
Malik E. Juweid is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 131 papers that have together received 8.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), Radiopharmaceutical Chemistry and Applications (35 papers), Medical Imaging Techniques and Applications (24 papers), Lung Cancer Treatments and Mutations (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Radiomics and Machine Learning in Medical Imaging (12 papers), Thyroid Cancer Diagnosis and Treatment (10 papers) and Medical Imaging and Pathology Studies (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.4k citations), Radiology, Nuclear Medicine and Imaging (2.9k citations), Neurology (1.3k citations), Genetics (888 citations) and Oncology (2.1k citations). Malik E. Juweid has collaborated with scholars based in United States, Jordan and Germany. Frequent co-authors include Bruce D. Cheson, Sigrid Stroobants, Julie M. Vose, Ahmad Tamimi, Randy D. Gascoyne, Sandra J. Horning, Beate Pfistner, Volker Diehl, Richard I. Fisher and Richard T. Hoppe. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, Nuclear Medicine Communications and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.